| P50 | author | David W. Denning | Q30533462 |
| P2093 | author name string | Lortholary O | |
| | Lefort A | |
| | Dromer F | |
| | Charlier C | |
| | Ribaud P | |
| | Hart E | |
| P2860 | cites work | Prophylactic intravenous antifungal agents to prevent mortality and morbidity in very low birth weight infants | Q24247461 |
| | Candida colonization and subsequent infections in critically ill surgical patients | Q24535524 |
| | Activity of UK-49,858, a bis-triazole derivative, against experimental infections with Candida albicans and Trichophyton mentagrophytes | Q28360287 |
| | Double-blind placebo-controlled trial of fluconazole to prevent candidal infections in critically ill surgical patients | Q28362691 |
| | Fluconazole prophylaxis against fungal colonization and infection in preterm infants | Q30308442 |
| | Infections in bone marrow transplant recipients | Q30465957 |
| | Fluconazole vs low-dose amphotericin B for the prevention of fungal infections in patients undergoing bone marrow transplantation: a study of the North American Marrow Transplant Group | Q31372000 |
| | Fluconazole for prophylaxis against candidal rectal colonization in the very low birth weight infant | Q31832758 |
| | Fluconazole therapy in Candida albicans spondylodiscitis | Q33538418 |
| | Impact of fluconazole prophylaxis on fungal colonization and infection rates in neutropenic patients. The Canadian Fluconazole Study. | Q51192355 |
| | Candidemia in allogeneic blood and marrow transplant recipients: evolution of risk factors after the adoption of prophylactic fluconazole. | Q51192827 |
| | Safety, plasma concentrations, and efficacy of high-dose fluconazole in invasive mold infections. | Q51194795 |
| | Fluconazole prophylaxis of fungal infections in patients with acute leukemia. Results of a randomized placebo-controlled, double-blind, multicenter trial. | Q51196036 |
| | Prophylactic action of oral fluconazole against fungal infection in neutropenic patients. A meta-analysis of 16 randomized, controlled trials. | Q54034991 |
| | Effects of fluconazole administration in critically ill patients: analysis of bacterial and fungal resistance. | Q54063081 |
| | Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation--a prospective, randomized, double-blind study. | Q54171057 |
| | Candida albicansEndophthalmitis in Brown Heroin Addicts: Response to Early Vitrectomy Preceded and Followed by Antifungal Therapy | Q58006237 |
| | An open study on the safety and efficacy of fluconazole in the treatment of disseminated Candida infections in patients treated for hematological malignancy | Q58840045 |
| | A randomized study to compare oral fluconazole to amphotericin B in the prevention of fungal infections in patients with acute leukaemia | Q44322995 |
| | Ocular fluconazole treatment of Candida parapsilosis endophthalmitis after failed intravitreal amphotericin B. | Q44338769 |
| | Attributable mortality of nosocomial candidemia, revisited | Q44386169 |
| | Candidal mitral endocarditis and long-term treatment with fluconazole in a patient with human immunodeficiency virus infection | Q44438547 |
| | A randomized and blinded multicenter trial of high-dose fluconazole plus placebo versus fluconazole plus amphotericin B as therapy for candidemia and its consequences in nonneutropenic subjects. | Q44440960 |
| | Management and outcome of bloodstream infections due to Candida species in England and Wales | Q44454722 |
| | Fluconazole improves survival in septic shock: a randomized double-blind prospective study | Q44504266 |
| | Cryptococcal meningitis in the acquired immunodeficiency syndrome (AIDS): successful treatment with fluconazole after failure of amphotericin B. | Q44551000 |
| | The European Confederation of Medical Mycology (ECMM) survey of candidaemia in Italy: antifungal susceptibility patterns of 261 non-albicans Candida isolates from blood. | Q44570705 |
| | Clinical spectrum of fungal infections after orthotopic liver transplantation | Q44572653 |
| | Successful treatment of Candida albicans osteomyelitis with fluconazole | Q44592917 |
| | Itraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplants | Q44606439 |
| | Epidemiology of candidemia in Swiss tertiary care hospitals: secular trends, 1991-2000. | Q44731146 |
| | Early diagnosis of candidiasis in non-neutropenic critically ill patients | Q44772991 |
| | Fluconazole therapy for chronic disseminated candidiasis in patients with leukemia and prior amphotericin B therapy | Q44822123 |
| | Medical treatment of recurrent candidemia in a patient with probable Candida parapsilosis prosthetic valve endocarditis | Q44868658 |
| | Action of fluconazole (UK-49,858) in relation to other systemic antifungal azoles | Q44918034 |
| | Stevens-Johnson syndrome after fluconazole | Q44958291 |
| | The treatment of systemic candidiasis in neonates with oral fluconazole | Q45085042 |
| | Randomized comparison between fluconazole and itraconazole for the treatment of candidemia in a pediatric intensive care unit: a preliminary study | Q45141879 |
| | Successful treatment of candidal osteomyelitis with fluconazole following failure with liposomal amphotericin B. | Q45256919 |
| | Fluconazole vs. amphotericin B for the treatment of neonatal fungal septicemia: a prospective randomized trial | Q45293251 |
| | Declining rates of oropharyngeal candidiasis and carriage of Candida albicans associated with trends toward reduced rates of carriage of fluconazole-resistant C. albicans in human immunodeficiency virus-infected patients. | Q45752667 |
| | A randomized trial comparing fluconazole with clotrimazole troches for the prevention of fungal infections in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group | Q45784081 |
| | Interaction of Azoles with Rifampin, Phenytoin, and Carbamazepine: In Vitro and Clinical Observations | Q46010998 |
| | Biliary concentrations of fluconazole in a patient with candidal cholecystitis: case report | Q46031471 |
| | Prophylaxis with weekly versus daily fluconazole for fungal infections in patients with AIDS. | Q46683801 |
| | A prospective study of the efficacy of fluconazole (UK-49,858) against deep-seated fungal infections | Q46815200 |
| | Candidal sepsis and meningitis in a very-low-birth-weight infant successfully treated with fluconazole and flucytosine | Q47369118 |
| | Clinical pharmacokinetics of fluconazole in superficial and systemic mycoses | Q48666983 |
| | Candida prosthetic arthritis: report of a case treated with fluconazole and review of the literature | Q40869061 |
| | Fungal infections in solid-organ transplantation | Q40914902 |
| | Spondylodiskitis due to Candida albicans: report of two patients who were successfully treated with fluconazole and review of the literature | Q41118044 |
| | Candida prosthetic valve endocarditis: prospective study of six cases and review of the literature | Q41136632 |
| | Successful treatment of fungal prosthetic valve endocarditis: case report and review | Q41136659 |
| | Management of invasive candidal infections: results of a prospective, randomized, multicenter study of fluconazole versus amphotericin B and review of the literature | Q41218000 |
| | Candida tropicalis arthritis in a patient with acute myeloid leukemia successfully treated with fluconazole: case report and review of the literature. | Q41434924 |
| | Plasma and tissue concentrations of fluconazole and their correlation to breakpoints | Q41566153 |
| | Pacemaker endocarditis due to Candida albicans: case report and review | Q41683234 |
| | Antifungal prophylaxis during remission induction therapy for acute leukemia fluconazole versus intravenous amphotericin B. | Q42285296 |
| | Safety evaluation of chronic fluconazole therapy. Fluconazole Pan-American Study Group | Q42547487 |
| | Weekly fluconazole for the prevention of mucosal candidiasis in women with HIV infection. A randomized, double-blind, placebo-controlled trial. Terry Beirn Community Programs for Clinical Research on AIDS. | Q42655153 |
| | Prospective study of fluconazole therapy in systemic neonatal fungal infection | Q42662478 |
| | The independent role of cytomegalovirus as a risk factor for invasive fungal disease in orthotopic liver transplant recipients. Boston Center for Liver Transplantation CMVIG-Study Group. Cytogam, MedImmune, Inc. Gaithersburg, Maryland. | Q42662774 |
| | Prosthetic joint infections with osteomyelitis due to Candida albicans | Q43486144 |
| | Pharmacokinetics of sequential intravenous and enteral fluconazole in critically ill surgical patients with invasive mycoses and compromised gastro-intestinal function | Q43560995 |
| | A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation | Q43619964 |
| | Summary of the Guidelines for Preventing Opportunistic Infections among Hematopoietic Stem Cell Transplant Recipients | Q43648274 |
| | Can fluconazole concentrations in saliva be used for therapeutic drug monitoring? | Q43690656 |
| | Evolution of antifungal susceptibility among Candida species isolates recovered from human immunodeficiency virus-infected women receiving fluconazole prophylaxis | Q43723795 |
| | Fluconazole prophylaxis for high-risk liver transplant recipients | Q43733935 |
| | Breakthrough fungemia caused by azole-resistant Candida albicans in neutropenic patients with acute leukemia | Q43756109 |
| | Randomized trial of fluconazole versus nystatin for the prophylaxis of Candida infection following liver transplantation. | Q43759182 |
| | Intravenous and oral itraconazole versus intravenous and oral fluconazole for long-term antifungal prophylaxis in allogeneic hematopoietic stem-cell transplant recipients. A multicenter, randomized trial | Q43801360 |
| | Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patients. | Q43823539 |
| | Case report. Successful treatment of two cases of post-surgical sternal osteomyelitis, due to Candida krusei and Candida albicans, respectively, with high doses of triazoles (fluconazole, itraconazole). | Q43839118 |
| | Treatment of two cases of cryptococcal meningitis with fluconazole | Q43913710 |
| | Fluconazole to prevent yeast infections in bone marrow transplantation patients: a randomized trial of high versus reduced dose, and determination of the value of maintenance therapy | Q43923731 |
| | Human herpesvirus 6 seronegativity before transplantation predicts the occurrence of fungal infection in liver transplant recipients | Q44054825 |
| | Antifungal prophylaxis for severely neutropenic chemotherapy recipients: a meta analysis of randomized-controlled clinical trials | Q44062340 |
| | Candidosis in the intensive care unit: a 20-year survey. | Q44062752 |
| | Efficacy, tolerability and development of resistance in HIV-positive patients treated with fluconazole for secondary prevention of oropharyngeal candidiasis: a randomized, double-blind, placebo-controlled trial | Q44088888 |
| | Randomized controlled trial of oral itraconazole solution versus intravenous/oral fluconazole for prevention of fungal infections in liver transplant recipients | Q44157199 |
| | Candida peritonitis due to peptic ulcer perforation: incidence rate, risk factors, prognosis and susceptibility to fluconazole and amphotericin B. | Q44176564 |
| | The discovery and profile of fluconazole | Q44230617 |
| | Comparison of caspofungin and amphotericin B for invasive candidiasis | Q44255071 |
| | Randomized comparison of oral fluconazole versus oral polyenes for the prevention of fungal infection in patients at risk of neutropenia. Multicentre Study Group | Q44308537 |
| | Successful treatment of Candida albicans osteomyelitis of the spine with fluconazole and surgical debridement: case report | Q44312899 |
| | Administration of fluconazole in children below 1 year of age. | Q33680336 |
| | Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America | Q33894467 |
| | Towards a targeted, risk-based, antifungal strategy in neutropenic patients | Q34022479 |
| | Hepatosplenic candidiasis. A manifestation of chronic disseminated candidiasis | Q34033236 |
| | Trends in mortality due to invasive mycotic diseases in the United States, 1980-1997. | Q34085884 |
| | 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer | Q34114674 |
| | Prevention of severe Candida infections in nonneutropenic, high-risk, critically ill patients: a randomized, double-blind, placebo-controlled trial in patients treated by selective digestive decontamination | Q34160563 |
| | Nosocomial candiduria: a review | Q34243460 |
| | Epidemiology of Candida species infections in critically ill non-immunosuppressed patients | Q34273626 |
| | Management of Candida species infections in critically ill patients | Q34280580 |
| | Epidemiology of fungal infections in solid organ transplant patients | Q34294864 |
| | Alopecia associated with fluconazole therapy | Q34301322 |
| | Micafungin versus fluconazole for prophylaxis against invasive fungal infections during neutropenia in patients undergoing hematopoietic stem cell transplantation | Q34368144 |
| | Therapeutic dilemma of fluconazole prophylaxis in intensive care | Q34509391 |
| | Predictive factors of mortality due to polymicrobial peritonitis with Candida isolation in peritoneal fluid in critically ill patients | Q35018807 |
| | Fungal infection in liver transplantation | Q35027481 |
| | Prevention of fungal infection in transplantation | Q35027499 |
| | Candida lusitaniae infections in the era of fluconazole availability | Q35043246 |
| | Candida glabrata spinal osteomyelitis involving two contiguous lumbar vertebrae: a case report and review of the literature | Q35076924 |
| | Fluconazole penetration in cerebral parenchyma in humans at steady state | Q35114601 |
| | An unusual cause of vertebral osteomyelitis: Candida species | Q35168358 |
| | Pharmacokinetics of fluconazole in cerebrospinal fluid and serum in human coccidioidal meningitis | Q35295703 |
| | Prophylaxis of invasive fungal infections in patients with hematological malignancies and solid tumors--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). | Q35298777 |
| | Twelve years of fluconazole in clinical practice: global trends in species distribution and fluconazole susceptibility of bloodstream isolates of Candida. | Q35641405 |
| | Geographic variation in the susceptibilities of invasive isolates of Candida glabrata to seven systemically active antifungal agents: a global assessment from the ARTEMIS Antifungal Surveillance Program conducted in 2001 and 2002. | Q35714132 |
| | Prophylactic use of fluconazole in neutropenic cancer patients | Q36679991 |
| | Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and candida infections. Subcommittee on Antifungal Susceptibility Te | Q36855581 |
| | Clinical features and analysis of risk factors for invasive candidal infection after marrow transplantation | Q37307622 |
| | Once-weekly fluconazole to prevent recurrence of oropharyngeal candidiasis in patients with AIDS and AIDS-related complex: a double-blind placebo-controlled study | Q39167869 |
| | Fluconazole in the treatment of candidiasis in immunocompromised children | Q40085911 |
| | Use of fluconazole in the treatment of candidal endophthalmitis. | Q40529533 |
| | Candidemia: the impact of antifungal prophylaxis in a surgical intensive care unit | Q40538538 |
| | Randomized trial of fluconazole versus low-dose amphotericin B in prophylaxis against fungal infections in patients undergoing hematopoietic stem cell transplantation | Q40570361 |
| | Worsening of liver function with fluconazole and review of azole antifungal hepatotoxicity | Q40582555 |
| | Association between antifungal prophylaxis and rate of documented bacteremia in febrile neutropenic cancer patients. | Q40603284 |
| | Antifungal chemoprophylaxis after blood and marrow transplantation | Q40643653 |
| | Candidal mediastinitis: an emerging clinical entity | Q40646177 |
| | Fungal prosthetic valve endocarditis in 16 patients. An 11-year experience in a tertiary care hospital | Q40654616 |
| | Candida albicans osteomyelitis in a liver transplant recipient: a case report and review of the literature | Q40662231 |
| | Fluconazole versus amphotericin B in the treatment of hematogenous candidiasis: a matched cohort study | Q40665851 |
| | Effect of prophylactic fluconazole on the frequency of fungal infections, amphotericin B use, and health care costs in patients undergoing intensive chemotherapy for hematologic neoplasias | Q40679794 |
| | Fluconazole in the management of fungal ocular infections | Q40692081 |
| | Fungal peritonitis in patients on peritoneal dialysis | Q40699236 |
| | Effect of fluconazole prophylaxis on fever and use of amphotericin in neutropenic cancer patients. Bone Marrow Transplantation Team | Q40703745 |
| | Hepatosplenic candidiasis: successful treatment with fluconazole | Q40746097 |
| | Candida lusitaniae osteomyelitis in a premature infant | Q40858155 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | candidiasis | Q273510 |
| | fluconazole | Q411478 |
| | invasive candidiasis | Q29887808 |
| | invasion management | Q113019190 |
| P1104 | number of pages | 27 | |
| P304 | page(s) | 384-410 | |
| P577 | publication date | 2006-01-31 | |
| P1433 | published in | Journal of Antimicrobial Chemotherapy | Q6294770 |
| P1476 | title | Fluconazole for the management of invasive candidiasis: where do we stand after 15 years? | |
| P478 | volume | 57 | |